Mounjaro
tirzepatide
FDA-approved for type-2 diabetes management. Once-weekly subcutaneous injection.
How it works
Mounjaro is the same molecule as Zepbound (tirzepatide), but its FDA approval is for type-2 diabetes rather than chronic weight management. It activates GIP and GLP-1 receptors to improve glucose control and reduce appetite.
How we use it
Mounjaro is prescribed within the GLP-1 Weight Optimization program for patients with type-2 diabetes whose physician determines it is the appropriate FDA-approved option. We do not market Mounjaro for weight loss — that indication belongs to Zepbound. Continuity is a priority — you will see the same physician whenever clinically possible.
What to expect
Once-weekly subcutaneous self-administered injection. Dose escalation per the diabetes label: 2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg, advancing approximately monthly per tolerance and glycemic response.
Adverse effects and contraindications
- Nausea during titration
- Diarrhea
- Constipation
- Reduced appetite
- Headache
- Injection-site irritation
- Pancreatitis — discontinue if suspected
- Gallbladder events
- Hypoglycemia when used in combination with insulin or a sulfonylurea
- Thyroid C-cell tumors — boxed warning per the FDA label
- Personal or family history of medullary thyroid carcinoma or MEN-2 syndrome
- Pregnancy or planned pregnancy in the next 2 months
- Severe gastroparesis
What the literature says
Published trials of tirzepatide in type-2 diabetes (the SURPASS program) report HbA1c reduction and weight reduction. Vayra does not claim specific outcomes for any patient.
How it reaches you
Branded Mounjaro is prescribed and dispensed via a separately licensed retail/specialty pharmacy partner at the dispensing pharmacy's published cash price; the exact figure is pulled at each visit and surfaced in your portal before you authorize routing. Vayra does not add a markup to medication.
Begin a documented physician visit.
Prescribing is the outcome of a clinical encounter, not a checkout flow. Your assessment takes about eight minutes; nothing is billed until you and your physician agree on a protocol.
Begin assessmentEight minutes to start. A lifetime of difference.
A Vayra-affiliated physician reviews your case within 24 hours. No insurance billed. Cancel anytime, two taps.